Melanotan-II response is blunted in the PVN of diet-induced obese rats, defending a higher body weight setpoint.
Background
Some individuals develop diet-induced obesity (DIO) on a high-energy diet (HED) and subsequently defend this higher body weight, even when returned to a low-energy diet. This suggests a shift in their metabolic 'setpoint'. The paraventricular nucleus (PVN) of the hypothalamus is a key regulatory center for this process. It integrates signals from anorexigenic melanocortins (which increase GABA release) and orexigenic neuropeptide Y (NPY, which inhibits it). This study investigates whether changes in sensitivity to these signals within the PVN could explain the persistent defense of a higher body weight in the DIO phenotype.
Study Design
The study used several groups of rats: diet-induced obese 'defenders' (DIO-D), diet-resistant (DR), and HED-naïve controls. After a period on a high-energy diet, DIO-D rats were returned to a low-energy diet. Researchers then measured the response of GABA inputs to PVN neurons to the melanocortin agonist Melanotan-II (MTII). They also assessed melanocortin-4 receptor (MC4R) expression in the dorsomedial hypothalamus and compared NPY responses across groups. The study also examined if MTII sensitivity could be restored by refeeding the DIO-D rats with the HED.
Results
After returning to a low-energy diet, the GABAergic inputs to PVN neurons from DIO-D rats showed a highly attenuated response to Melanotan-II compared to both DR and HED-naïve rats. This loss of sensitivity points to a specific blunting of the anorexigenic melanocortin pathway. Correspondingly, MC4R expression was significantly reduced in the dorsomedial hypothalamus of DIO-D rats, a primary source of GABA input to the PVN. In contrast, the action of the orexigenic neuropeptide Y (NPY) was unchanged in the PVN of DIO-D rats.
Crucially, this lost sensitivity to MTII was not permanent; it was fully restored in DIO-D rats after several weeks of refeeding with a high-energy diet. This suggests the melanocortin system remains plastic, capable of adjusting its sensitivity around the elevated body weight setpoint.
Key Findings
- In diet-induced obese (DIO-D) rats, GABA inputs to PVN neurons showed 'highly attenuated' responses to Melanotan-II.
- Melanocortin-4 receptor (
MC4R) expression was 'significantly reduced' in the dorsomedial hypothalamus of DIO-D rats. - The action of neuropeptide Y (NPY) in the PVN of DIO-D rats was unchanged compared to controls.
- Melanotan-II sensitivity was restored in DIO-D rats after several weeks of refeeding with a high-energy diet.
Why It Matters
This research provides a powerful mechanistic explanation for why it is so difficult for some individuals to maintain weight loss after a period of obesity. The findings suggest the brain actively defends the higher 'setpoint' by downregulating its sensitivity to satiety signals like those mediated by melanocortins. For users of melanocortin agonists like Melanotan-II, this implies that efficacy for appetite suppression may be significantly reduced in a state of diet-induced obesity, especially after returning to a caloric deficit. The brain's adaptation may require a different therapeutic approach than simply administering an anorexigenic peptide, as the target receptors themselves have become less responsive. The restoration of sensitivity with HED refeeding suggests a complex, dynamic regulation that could complicate long-term weight management strategies.
